About Centivax
Centivax is a company based in San Francisco (United States) founded in 2019. Centivax has raised $92 million across 5 funding rounds from investors including NIH, US Navy and Gates Foundation. Centivax offers products and services including Broad-Spectrum Vaccine. Centivax operates in a competitive market with competitors including Medeloop, Pure Biologics, Hyku Biosciences, Sirion Biotech and Taizhou Baiying Biotechnology, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$92 M (USD)
in 5 rounds
-
Latest Funding Round
$37 M (USD), Series A
Mar 30, 2026
-
Investors
NIH
& 14 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Centivax
Centivax offers a comprehensive portfolio of products and services, including Broad-Spectrum Vaccine.
Pre-clinical vaccine for preventing all influenza strains in animals.
People of Centivax
Unlock access to complete
Unlock access to complete
Funding Insights of Centivax
Centivax has successfully raised a total of $92M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $37 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Centivax
Centivax has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include NIH, US Navy and Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm offering funding and tools for startups in technology and investment sectors.
|
Locked | Locked | Locked | |
|
Future Ventures is focused on early-stage venture capital investments.
|
Locked | Locked | Locked | |
|
Early-stage life sciences and tech focused VC firm investing primarily in the US
|
Locked | Locked | Locked |
Investor details for Centivax
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Centivax
Investment portfolio details for Centivax
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Centivax
Detailed financials for Centivax
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Centivax Comparisons
Peer comparison for Centivax
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Centivax
Centivax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medeloop, Pure Biologics, Hyku Biosciences, Sirion Biotech and Taizhou Baiying Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery services are offered by Medeloop as a CRO.
|
|
| Locked | Locked | Locked |
Specialized CRO with expertise in recombinant protein production and purification
|
|
| Locked | Locked | Locked |
Covalent medicines platform is advanced for drug discovery targeting proteins.
|
|
| Locked | Locked | Locked |
Customized AAV-based viral vectors for gene therapy are supplied.
|
|
| Locked | Locked | Locked |
Antibody-drug research and development services are provided.
|
Detailed competitors of Centivax
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Centivax
Complete news archive for Centivax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Centivax
Centivax was founded in 2019.
Centivax is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Centivax is a funded company, having raised a total of $92M across 5 funding rounds to date.
Centivax was established in 2019 and is based in San Francisco, United States. Drug discovery services are offered by the company within the biotechnology sector, focusing on early-stage research and development for therapeutics. Operations include target identification, compound screening, and preclinical validation, conducted by a team leveraging the regions scientific resources. The domain centivax.com is utilized for online presence and client engagement.
Centivax's top competitors include Medeloop, Pure Biologics and Sirion Biotech.
Centivax offers Broad-Spectrum Vaccine.
Centivax has 15 investors. Key investors include NIH, US Navy, Gates Foundation, HHS, and CEPI.